A detailed history of Wealth Trust Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wealth Trust Asset Management, LLC holds 4,812 shares of ABBV stock, worth $851,483. This represents 0.72% of its overall portfolio holdings.

Number of Shares
4,812
Previous 4,797 0.31%
Holding current value
$851,483
Previous $822,000 15.57%
% of portfolio
0.72%
Previous 0.61%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $2,457 - $2,989
15 Added 0.31%
4,812 $950,000
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $2,631 - $3,072
17 Added 0.36%
4,797 $822,000
Q1 2024

May 03, 2024

SELL
$159.82 - $182.1 $6,872 - $7,830
-43 Reduced 0.89%
4,780 $870,000
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $5,228 - $5,888
38 Added 0.79%
4,823 $747,000
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $69,199 - $80,108
-518 Reduced 9.77%
4,785 $713,000
Q2 2023

Aug 04, 2023

BUY
$132.51 - $164.9 $16,033 - $19,952
121 Added 2.34%
5,303 $714,000
Q1 2023

Apr 28, 2023

BUY
$144.61 - $166.54 $2,458 - $2,831
17 Added 0.33%
5,182 $825,000
Q4 2022

Feb 06, 2023

SELL
$138.31 - $165.87 $52,419 - $62,864
-379 Reduced 6.84%
5,165 $835,000
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $15,165 - $17,394
113 Added 2.08%
5,544 $744,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $5,091 - $6,473
-37 Reduced 0.68%
5,431 $832,000
Q1 2022

May 27, 2022

SELL
$131.98 - $163.75 $30,355 - $37,662
-230 Reduced 4.04%
5,468 $886,000
Q4 2021

May 27, 2022

SELL
$107.43 - $135.93 $9,346 - $11,825
-87 Reduced 1.5%
5,698 $772,000
Q3 2021

Oct 27, 2021

SELL
$106.4 - $120.78 $2.19 Million - $2.49 Million
-20,585 Reduced 78.06%
5,785 $624,000
Q2 2021

Jul 09, 2021

BUY
$105.21 - $117.21 $2.77 Million - $3.09 Million
26,370 New
26,370 $2.97 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Wealth Trust Asset Management, LLC Portfolio

Follow Wealth Trust Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Trust Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Trust Asset Management, LLC with notifications on news.